Philip S. Low

Next Generation Targeted Therapeutics



Purdue News: FDA approves pioneering drug for ovarian cancer surgery

FDA Approves ‘Illuminating’ Drug for Spotting Cancer

FDA Approves Cytalux

Novartis’ radioligand therapy meets phase 3 prostate cancer trial target

On Target Laboratories Announces U.S. FDA Acceptance and Priority Review of New Drug Application for pafolacianine sodium injection for Identification of Ovarian Cancer During Surgery


New Cancer Immunotherapy

Inside Indiana Business

Endpoints – MPM backs $53M round for a bold concept: Let patients make their own CAR-T in vivo:

Pulmonary Fibrosis News -



Successful Purdue entrepreneurs provide targeted advice to faculty and staff entrepreneurs entering startup world

Purdue startup sold in $2.1B pharma deal

Purdue startup Endocyte sold in $2.1B deal with pharmaceutical giant Novartis

$2.1B Endocyte Deal a Record-Breaker

Great Minds Talk Cancer

$1.7 million SBIR grant fast-tracks faster bone fracture healing

Indiana life sciences firms raise record $111M in venture capital in 2017

Prof. Philip S. Low gives a talk on targeted therapy at IISc


Purdue-based biotech company aims to treat cancer by making cancer cells appear to glow

Desi scientist in US discovers molecule that illuminates cancer cells


Purdue research may expand engineered T-cell cancer treatment

Purdue Centre for Drug Discovery Targeting Tumors with Engineered T-Cell Therapy

Research could expand engineered T-cell cancer treatment


Not-for-profit startup aims to evaluate Purdue drug compounds before clinical trials

Dr. Philip Low Honored With 2015 AACR Award for Outstanding Achievement in Chemistry in Cancer Research


On Target Laboratories begins Phase 2 clinical trials for its cancer imaging agent

New technology could 'light up' cancer cells and improve surgical outcomes

Purdue University discovery leads to Endocyte drug


Endocyte founder Philip S. Low awarded BioCrossroads 2013 Watanabe Life Sciences Champion of the Year


Glow-In-the-Dark Cells Help Find Ovarian Cancer